Considering the importance of PI3K/Akt signaling for CSC induction and maintenance in breast cancer, its long-term activation could contribute to developing the treatment-resistant, basal-like phenotype in BRCA1-mutant tumors [99]. The gene discussed is AKT1; the disease is breast cancer.